Publication:
Effect of agmatine on impairment of hippocampal neurogenesis and neuroinflammation in streptozotocin-induced diabetes

dc.contributor.authorARICIOĞLU, FEYZA
dc.contributor.authorsZortul, H.; Aricioglu, F.; Hafez, G.; Yazir, Y.; Utkan, T.
dc.date.accessioned2022-03-12T16:24:23Z
dc.date.accessioned2026-01-11T11:03:11Z
dc.date.available2022-03-12T16:24:23Z
dc.date.issued2019
dc.identifier.doi10.1016/j.euroneuro.2018.11.416
dc.identifier.eissn1873-7862
dc.identifier.issn0924-977X
dc.identifier.urihttps://hdl.handle.net/11424/226324
dc.identifier.wosWOS:000458400500354
dc.language.isoeng
dc.publisherELSEVIER
dc.relation.ispartofEUROPEAN NEUROPSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEffect of agmatine on impairment of hippocampal neurogenesis and neuroinflammation in streptozotocin-induced diabetes
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS261
oaire.citation.startPageS260
oaire.citation.titleEUROPEAN NEUROPSYCHOPHARMACOLOGY
oaire.citation.volume29

Files